News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Levine James E.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/16/2023 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 197,472 options
@ $1.72, valued at
$339.7k
|
|
| 09/19/2022 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Bought 30,000 shares
@ $1.557, valued at
$46.7k
|
|
| 03/10/2022 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 170,016 options
@ $2.5, valued at
$425k
|
|
| 09/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/12/2021 |
4
| Levine James E. (CFO) has filed a Form 4 on Cardiff Oncology, Inc.|
Txns:
| Granted 390,000 options to buy
@ $6.55, valued at
$2.6M
|
|
| 07/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/12/2020 |
4
| Levine James E. (CFO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 50,000 shares
@ $2.0144, valued at
$100.7k
|
|
| 03/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/23/2020 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2019 |
4
| Levine James E. (CFO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Bought 30,000 shares
@ $1.908, valued at
$57.2k
|
|
| 12/04/2018 |
4
| Levine James E. (CFO) has filed a Form 4 on Cidara Therapeutics, Inc.|
Txns:
| Granted 175,000 options to buy
@ $3.62, valued at
$633.5k
|
|
| 12/04/2018 |
3
| Levine James E. (CFO) has filed a Form 3 on Cidara Therapeutics, Inc. |
| 11/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/02/2013 |
4
| Levine James E. (President & CEO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 24,063 options to buy
@ $2.18, valued at
$52.5k
Granted 10,937 options to buy
@ $2.18, valued at
$23.8k
|
|
| 08/03/2012 |
4
| Levine James E. (CEO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 13,125 options to buy
@ $4.23, valued at
$55.5k
Granted 16,875 options to buy
@ $4.23, valued at
$71.4k
|
|
| 05/16/2012 |
4
| Levine James E. (CEO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Bought 4,994 shares
@ $3.65, valued at
$18.2k
|
|
| 08/29/2011 |
4
| Levine James E. (CEO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Bought 25,000 shares
@ $3.18, valued at
$79.5k
|
|
| 08/16/2011 |
4
| Levine James E. (EVP, CEO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Bought 25,000 shares
@ $1.69, valued at
$42.3k
|
|
| 09/09/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2010 |
4
| Levine James E. (EVP, CFO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Bought 24,856 shares
@ $2.5, valued at
$62.1k
Bought 25,150 shares
@ $2.51, valued at
$63.1k
|
|
| 05/19/2010 |
4/A
| Levine James E. (EVP, CFO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 20,833 options to buy
@ $3.85, valued at
$80.2k
|
|
| 12/15/2009 |
4
| Levine James E. (EVP, CFO) has filed a Form 4 on VERENIUM CORP|
Txns:
| Granted 20,000 options to buy
@ $4.12, valued at
$82.4k
|
|
| 05/27/2009 |
4
| Form 4 -- Statement of changes in beneficial ownership of securities |
| 05/07/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|